Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | NOTUM | Q6P988 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | GPR27 | Q9NS67 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.37 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.37 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.37 |
| ▸ | TAS1R2 | Q8TE23 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | ALPL | P05186 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30610932 | 1.00 | CYP3A4 (0.42) | CYP3A4MAPK1NOTUMTSHRGPR27 | |
| SCHEMBL4509639 | 0.82 | DPP4 (0.43) | CYP3A4MAPK1NOTUMTSHRALDH1A1 | |
| SCHEMBL9501959 | 0.82 | MAPK1 (0.39) | CYP3A4MAPK1NOTUMTSHRALDH1A1 | |
| SCHEMBL6585808 | 0.82 | MAPT (0.39) | CYP3A4MAPK1NOTUMTSHRALDH1A1 | |
| SCHEMBL11658669 | 0.80 | ALDH1A1 (0.38) | CYP3A4MAPK1NOTUMTSHRALDH1A1 | |
| SCHEMBL750562 | 0.80 | ALDH1A1 (0.38) | CYP3A4MAPK1NOTUMTSHRALDH1A1 | |
| SCHEMBL10964869 | 0.80 | KMT2A (0.37) | CYP3A4MAPK1NOTUMTSHRKMT2A | |
| SCHEMBL16958284 | 0.80 | CYP3A4 (0.46) | CYP3A4MAPK1NOTUMTSHRGPR27 | |
| SCHEMBL699212 | 0.79 | TSHR (0.65) | CYP3A4TSHRALDH1A1TAS1R3TAS1R1 | |
| SCHEMBL6247069 | 0.79 | MAPK1 (0.46) | CYP3A4MAPK1ALDH1A1MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0674233-B1 | Recording sheets | XEROX CORP (US) | 2000-05-24 | — | — | EP | claimed |
| US-6013839-A | REACTING A 2,4-DIHALOACETOPHENONE WITH A THIOLATING AGENT UNDER ANHYDROUS CONDITIONS; EFFICIENCY; INTERMEDIATES OF HERBICIDES E.G., BENZAMIDE DERIVATIVES | RHONE-POULENC AGRICULTURE LIMITED (GB) | 2000-01-11 | — | — | US | claimed |
| US-5928765-A | Recording sheets | XEROX CORPORATION (US) | 1999-07-27 | — | — | US | claimed |
| EP-0674233-A2 | Recording sheets | XEROX CORPORATION (US) | 1995-09-27 | — | — | EP | claimed |
| US-4417957-A | CHLORINATED ACETOPHENONES; ACRYLIC ACID AND/OR METHACRYLIC ACID | COLUMBIA CHEMICAL CORPORATION (US) | 1983-11-29 | — | — | US | claimed |
| CN-116970580-A | Short-chain dehydrogenase mutant derived from Raffina and application of short-chain dehydrogenase mutant in catalyzing aryl ketone to prepare chiral alcohol | 浙江工业大学 | 2023-10-31 | — | — | CN | disclosed |
| WO-2022104049-A1 | SYNTHESIS OF ARYL 1-(METHOXYMETHYL) VINYL KETONES AND THEIR USE AS INHIBITORS OF MILD STEEL CORROSION | SAUDI ARABIAN OIL COMPANY (SA) | 2022-05-19 | — | — | WO | disclosed |
| US-20220145179-A1 | SYNTHESIS OF ARYL 1-(METHOXYMETHYL) VINYL KETONES AND THEIR USE AS INHIBITORS OF MILD STEEL CORROSION | SAUDI ARABIAN OIL COMPANY (SA) | 2022-05-12 | — | — | US | disclosed |
| WO-2019056247-A1 | TRIAZINONE DERIVATIVE CONTAINING ACYLHYDRAZONE STRUCTURE AND PREPARATION METHOD THEREFOR, AND INSECTICIDAL AND BACTERICIDAL USES THEREOF | 南开大学 | 2019-03-28 | — | — | WO | disclosed |
| EP-2285787-B1 | 3-SUBSTITUTED PROPANAMINE COMPOUNDS | SK BIOPHARMACEUTICALS CO LTD (KR) | 2015-08-26 | — | — | EP | disclosed |
| US-8404730-B2 | 3-substituted propanamine compounds | SK BIOPHARMACEUTICALS CO., LTD. (KR) | 2013-03-26 | — | — | US | disclosed |
| EP-2570418-A2 | 2,3-dihydro-6-nitroimidazo[2,1-b]oxazoles compound | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2013-03-20 | — | — | EP | disclosed |
| WO-1992006085-A1 | PHENYLPYRIDINOL DERIVATIVES AS MEDICAMENTS | SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) | 1992-04-16 | — | — | WO | disclosed |
| US-5075488-A | Fungicides | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-12-24 | — | — | US | disclosed |
| EP-0128006-B1 | A SOIL-DISEASE-CONTROLLING AGENT | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-09-18 | — | — | EP | disclosed |
| US-4709052-A | FUNGICIDES | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1987-11-24 | — | — | US | disclosed |
| US-4515793-A | PARASITICIDES | EDNA MCCONNELL CLARK FOUNDATION (US) | 1985-05-07 | — | — | US | disclosed |
| EP-0128006-A2 | A soil-disease-controlling agent | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1984-12-12 | — | — | EP | disclosed |
| US-4297435-A | CONSISTING OF A TRIARYLMETHANE LEUCO DYE AND A BROMO-SUBSTITUTED CYCLOHEXANE | HERCULES INCORPORATED (US) | 1981-10-27 | — | — | US | disclosed |
| US-4283334-A | DIURETICS | AMERICAN CYANAMID COMPANY (US) | 1981-08-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220145179-A1 | SYNTHESIS OF ARYL 1-(METHOXYMETHYL) VINYL KETONES AND THEIR USE AS INHIBITORS OF MILD STEEL CORROSION | PAH, CYP2F1, ADH1C | CYP3A4 100/4885MAPK1 569/4885NOTUM 459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.